Effective Reduction of SARS-CoV-2 RNA Levels Using a Tailor-Made Oligonucleotide-Based RNA Inhibitor

In only two years, the coronavirus disease 2019 (COVID-19) pandemic has had a devastating effect on public health all over the world and caused irreparable economic damage across all countries. Due to the limited therapeutic management of COVID-19 and the lack of tailor-made antiviral agents, findin...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Veronika Nemethova, Petra Mazancova, Michal Selc, Kristina Jakic, Lucia Uhelska, Boglarka Nemethova, Alexandra Poturnayova, Lubos Drgona, Andrea Babelova, Filip Razga
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI AG 2022-03-01
Sarja:Viruses
Aiheet:
SARS-CoV-2
COVID-19
RNA levels
oligonucleotide-based RNA inhibitor
RdRp
Linkit:https://www.mdpi.com/1999-4915/14/4/685
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia